Loading [MathJax]/jax/output/HTML-CSS/fonts/TeX/fontdata.js

Journal List > J Korean Ophthalmol Soc > v.57(9) > 1010391

Kim, Tumurbaatar, Ohn, Ha, and Park: Cerebrospinal Fluid Pressure and Trans-lamina Cribrosa Pressure Difference in Open-angle Glaucoma: KNHANES V

Abstract

Purpose

To investigate the relationships between estimated cerebrospinal fluid pressure (CSFP) and trans-lamina cribrosa pressure difference (TLCPD) in open-angle glaucoma (OAG) in Korean population.

Methods

A total of 10,801 eyes were included from the Korean National Health and Nutrition Examination Survey V. All participants (aged 19 years or older) were classified as non-glaucomatous group, OAG suspect group and OAG group. CSFP was calculated as CSFP (mm Hg) = 0.44 body mass index (kg/m2) + 0.16 diastolic blood pressure (mm Hg) – 0.18 age (years) – 1.91. TLCPD was calculated by subtracting CSFP from intraocular pressure.

Results

The mean estimated CSFP was (8.7 ± 3.3 mm Hg vs. 11.6 ± 3.7 mm Hg, 11.2 ± 3.8 mm Hg vs. 11.6 ± 3.7 mm Hg) was lower, and the mean TLCPD (5.7 ± 4.4 mm Hg vs. 2.2 ± 4.4 mm Hg, 3 ± 4.7 mm Hg vs. 2.2 ± 4.4 mm Hg) was higher in the OAG group and in the OAG suspect group than in the non-glaucomatous control group, respectively (p < 0.001). After adjusting relating factor with CSFP and TLCPD using simple linear regression and multivariate analyses, the mean estimated CSFP was distributed lower (p < 0.001; beta: −0.12; B: −2.306; 95% confidence interval [CI]: −2.717, −1.895) in OAG group than in nonglaucomatous group and the mean TLCPD was distributed higher (p < 0.001; beta: 0.099; B: 1.349; 95% CI: 0.977, 1.72; p < 0.001; beta: 0.118; B: 2.776; 95% CI: 2.264, 3.289) in OAG suspect group and in OAG group than in non-glaucomatous group, respectively.

Conclusions

Estimated CSFP and calculated TLCPD showed essential association with OAG presence. It supports the potential role of low CSFP in the pathogenesis of OAG.

Go to : Goto

References

1. Crawford Downs J, Roberts MD, Sigal IA. Glaucomatous cupping of the lamina cribrosa: a review of the evidence for active abdominal remodeling as a mechanism. Exp Eye Res. 2011; 93:133–40.
2. Yablonski M, Ritch R, Pokorny KS. Effect of decreased abdominal pressure on optic disk. Invest Ophthalmol Vis Sci. 1979; 18(Suppl):165.
3. Jonas JB, Berenshtein E, Holbach L. Anatomic relationship abdominal lamina cribrosa, intraocular space, and cerebrospinal fluid space. Invest Ophthalmol Vis Sci. 2003; 44:5189–95.
4. Morgan WH, Yu DY, Cooper RL, et al. The influence of abdominal fluid pressure on the lamina cribrosa tissue pressure gradient. Invest Ophthalmol Vis Sci. 1995; 36:1163–72.
5. Morgan WH, Chauhan BC, Yu DY, et al. Optic disc movement with variations in intraocular and cerebrospinal fluid pressure. Invest Ophthalmol Vis Sci. 2002; 43:3236–42.
6. Morgan WH, Yu DY, Alder VA, et al. The correlation between cerebrospinal fluid pressure and retrolaminar tissue pressure. Invest Ophthalmol Vis Sci. 1998; 39:1419–28.
7. Marek B, Harris A, Kanakamedala P, et al. Cerebrospinal fluid pressure and glaucoma: regulation of trans-lamina cribrosa pressure. Br J Ophthalmol. 2014; 98:721–5.
crossref
8. Ren R, Jonas JB, Tian G, et al. Cerebrospinal fluid pressure in abdominal: a prospective study. Ophthalmology. 2010; 117:259–66.
9. Xie X, Zhang X, Fu J, et al. Noninvasive intracranial pressure abdominal by orbital subarachnoid space measurement: the Beijing Intracranial and Intraocular Pressure (iCOP) study. Crit Care. 2013; 17:R162.
10. Jonas JB, Nangia V, Wang N, et al. Trans-lamina cribrosa pressure difference and open-angle glaucoma. The central India eye and medical study. PLoS One. 2013; 8:e82284.
crossref
11. Jonas JB, Wang NL, Wang YX, et al. Estimated trans-lamina cribrosa pressure difference versus intraocular pressure as biomarker for open-angle glaucoma. The Beijing Eye Study 2011. Acta Ophthalmol. 2015; 93:e7–e13.
crossref
12. Wang YX, Jonas JB, Wang N, et al. Intraocular pressure and estimated cerebrospinal fluid pressure. The Beijing Eye Study 2011. PLoS One. 2014; 9:e104267.
crossref
13. Yoon KC, Mun GH, Kim SD, et al. Prevalence of eye diseases in South Korea: data from the Korea National Health and Nutrition Examination Survey 2008–2009. Korean J Ophthalmol. 2011; 25:421–33.
crossref
14. Foster PJ, Buhrmann R, Quigley HA, Johnson GJ. The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol. 2002; 86:238–42.
crossref
15. Berdahl JP, Allingham RR, Johnson DH. Cerebrospinal fluid pressure is decreased in primary open-angle glaucoma. Ophthalmology. 2008; 115:763–8.
crossref
16. Berdahl JP, Fautsch MP, Stinnett SS, Allingham RR. Intracranial pressure in primary open angle glaucoma, normal tension glaucoma, and ocular hypertension: a case-control study. Invest Ophthalmol Vis Sci. 2008; 49:5412–8.
crossref
17. Guidoboni G, Harris A, Carichino L, et al. Effect of intraocular pressure on the hemodynamics of the central retinal artery: a mathematical model. Math Biosci Eng. 2014; 11:523–46.
crossref
18. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006; 90:262–7.
crossref
19. Kim CS, Seong GJ, Lee NH, et al. Prevalence of primary open-angle glaucoma in central South Korea the Namil study. Ophthalmology. 2011; 118:1024–30.
Go to : Goto

jkos-57-1392f1.tif
Figure 1.
Distribution of estimated cerebrospinal fluid pressure. Estimated cerebrospinal fluid pressure (CSFP) was calculated after adjustment for glaucoma status, sex, log-transformed pulse, total cholesterol, log-transformed triglycerides, corneal refractive power, anterior chamber depth, vertical cup-to-ratio, and intraocular pressure.
undefined
jkos-57-1392f2.tif
Figure 2.
Distribution of estimated trans-lamina cribrosa pressure difference. Estimated trans-lamina cribrosa pressure difference (TLCPD) was calculated after adjustment for glaucoma status, sex, log-transformed pulse, corneal refractive power, anterior chamber depth, and vertical cup-to-disc ratio.
undefined
Table 1.
Characteristic per groups
Variable Normal Glaucoma suspect Glaucoma Total Comparison (p-value*)
By patient N = 4,911 N = 895 N = 326 N = 6,132  
 Age (years) 50.8 ± 16.6 54.4 ± 15.7 65.5 ± 11.7 52.1 ± 16.6 <0.0011–2,1–3,2–3
 Sex (n, %)
  Male 1,995 (40.6) 462 (51.6) 152 (46.6) 2,609 (42.5) <0.0011–2
  Female 2,916 (59.4) 433 (48.4) 174 (53.4) 3,523 (57.5)  
 BMI (kg/m2) 23.7 ± 3.4 23.9 ± 3.2 23.7 ± 3.2 23.8 ± 3.4 0.510
 Systolic BP (mm Hg) 119.3 ± 16.9 122.2 ± 18.1 126.6 ± 17.6 120.1 ± 17.2 <0.0011–2,1–3,2–3
 Diastolic BP (mm Hg) 75.6 ± 10.4 76.7 ± 10.3 75.0 ± 10.1 75.7 ± 10.4 0.0041–2,2–3
 Pulse (beats/15 sec) 17.6 ± 2.0 14.1 ± 3.0 17.5 ± 2.1 17.1 ± 2.6 <0.0011–2,2–3
 Total cholesterol (mg/dL) 189.7 ± 36.6 188.1 ± 35.7 190.2 ± 36.2 189.5 ± 36.5 0.468
 HDL cholesterol (mg/dL) 51.8 ± 12.7 50.5 ± 12.6 48.4 ± 11.1 51.5 ± 12.6 <0.0011–2,1–3,2–3
 Triglycerides (mg/dL) 130.5 ± 130.9 137.1 ± 106.7 147.1 ± 81.0 132.3 ± 103.3 0.0101–3
By eye N = 9,149 N = 1,224 N = 428 N = 10,801  
 Corneal refractive power (diopter) −0.8 ± 2.2 −0.7 ± 2.1 −0.7 ± 3.0 −0.8 ± 2.2 0.048
 ACD 2.8 ± 0.5 2.7 ± 0.5 2.7 ± 0.6 2.8 ± 0.5 <0.0011–3
 Vertical CDR 0.3 ± 0.1 0.6 ± 0.1 0.7 ± 0.2 0.4 ± 0.1 <0.0011–2,1–3,2–3
 Horizontal CDR 0.3 ± 0.1 0.6 ± 0.1 0.6 ± 0.2 0.4 ± 0.1 <0.0011–2,1–3,2–3
 Estimated CSFP (mm Hg) 11.6 ± 3.7 11.2 ± 3.8 8.7 ± 3.3 11.4 ± 3.7 <0.0011–2,1–3,2–3
 IOP (mm Hg) 13.7 ± 2.7 14.2 ± 3.0 14.4 ± 3.4 13.8 ± 2.8 <0.0011–2,1–3
 TLCPD (mm Hg) 2.2 ± 4.4 3.0 ± 4.7 5.7 ± 4.4 2.4 ± 4.5 <0.0011–2,1–3,2–3

Values are presented as mean ± SD unless otherwise indicated.

BMI = body mass index; BP = blood pressure; HDL = high-density lipoprotein; ACD = anterior chamber depth; CDR = cup-to-disc ratio; CSFP = cerebrospinal fluid pressure; IOP = intraocular pressure; TLCPD = trans-lamina cribrosa pressure difference.

* p-values were calculated by analysis of variance (ANOVA) assuming unequal variance for continuous variables and Chi-square test for categorical variables. Posthoc comparison by Scheffe's method: i-j means that i-th group had significant differences (i, j = 1, 2, 3; Group 1 = Normal, Group 2 = Glaucoma suspect, Group 3 = Glaucoma).

Table 2.
Linear regression analysis for cerebrospinal fluid pressure
Variable Univariable
Multivariable
B 95% CI Beta p-value B 95% CI Beta p-value VIF
Glaucoma suspect (vs. Normal) −0.348 −0.566, −0.130 −0.030 0.002 0.241 −0.056, 0.538 0.022 0.111 0.000
Galucoma (vs. Normal) −2.871 −3.226, −2.516 −0.151 <0.001 −2.306 −2.717, −1.895 −0.120 <0.001 2.594
Male (ref: Female) 0.869 0.728, 1.009 0.116 <0.001 0.870 0.730, 1.009 0.120 <0.001 1.093
Systolic BP (mm Hg)* −0.140 −0.646, 0.366 −0.005 0.588          
Pulse (beats/15sec)* 1.992 1.514, 2.469 0.082 <0.001 1.502 0.969, 2.035 0.063 <0.001 1.485
Total cholesterol (mg/dL) 0.004 0.002, 0.006 0.041 <0.001 0.003 0.001, 0.005 0.028 0.005 1.162
HDL cholesterol (mg/dL) −0.003 −0.009, 0.002 −0.012 0.228          
Triglycerides (mg/dL)* 0.592 0.472, 0.712 0.095 <0.001 0.599 0.474, 0.724 0.098 <0.001 1.234
Corneal refractive power (diopter) −0.579 −0.609, −0.549 −0.345 <0.001 −0.539 −0.569, −0.509 −0.337 <0.001 1.041
ACD 1.154 1.006, 1.032 0.146 <0.001 0.691 0.548, 0.835 0.089 <0.001 1.027
Vertical CDR −2.578 −3.059, −2.097 −0.101 <0.001 −1.178 −1.832, −0.525 −0.048 <0.001 2.073
Horizontal CDR −2.322 −2.817, −1.826 −0.088 <0.001          
IOP (mm Hg) 0.086 0.061, 0.111 0.065 <0.001 0.034 0.009, 0.059 0.027 0.007 1.110

B = regression coefficient; CI = confidence interval; Beta = standardized regression coefficient; VIF = variance inflation factor; BP = blood pressure; HDL = high-density lipoprotein; ACD = anterior chamber depth; CDR = cup-to-disc ratio; IOP = intracular pressure.

* Natural logarithmic transformations were performed before analysis.

Table 3.
Linear regression analysis trans-lamina cribrosa pressure difference
Variable Univariable
Multivariable
B 95% CI Beta p-value B 95% CI Beta p-value VIF
Glaucoma suspect (vs. Normal) 0.798 0.533, 1.062 0.056 <0.001 1.349 0.977, 1.720 0.099 <0.001 0.000
Galucoma (vs. Normal) 3.537 3.107, 3.967 0.154 <0.001 2.776 2.264, 3.289 0.118 <0.001 2.579
Male (ref: Female) −0.614 −0.785, −0.442 −0.067 <0.001 −0.740 −0.910, −0.570 −0.081 <0.001 1.018
Systolic BP (mm Hg)* 2.257 1.644, 2.869 0.069 <0.001          
Pulse (beats/15 sec)* 2.090 1.509, 2.671 0.070 <0.001 4.604 3.964, 5.243 0.155 <0.001 1.362
Total cholesterol (mg/dL) −0.001 −0.003, 0.002 −0.006 0.538          
HDL cholesterol (mg/dL) −0.008 −0.015, −0.002 −0.024 0.015          
Triglycerides (mg/dL)* −0.100 −0.247, 0.047 −0.013 0.185          
Corneal refractive power (diopter) 0.506 0.468, 0.543 0.248 <0.001 0.492 0.454, 0.530 0.244 <0.001 1.030
ACD −1.134 −1.314, −0.954 −0.118 <0.001 −0.729 −0.909, −0.549 −0.076 <0.001 1.026
Vertical CDR 4.303 3.722, 4.884 0.138 <0.001 2.446 1.623, 3.268 0.080 <0.001 2.090
Horizontal CDR 3.903 3.304, 4.501 0.122 <0.001          

B = regression coefficient; CI = confidence interval; Beta = standardized regression coefficient; VIF = variance inflation factor; BP = blood pressure; HDL = high-density lipoprotein; ACD = anterior chamber depth; CDR = cup-to-disc ratio.

* Natural logarithmic transformations were performed before analysis.

TOOLS
Similar articles